772 related articles for article (PubMed ID: 15599148)
1. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
[TBL] [Abstract][Full Text] [Related]
2. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
[TBL] [Abstract][Full Text] [Related]
3. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
[TBL] [Abstract][Full Text] [Related]
6. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control.
Bellomo R; Farmer M; Bhonagiri S; Porceddu S; Ariens M; M'Pisi D; Ronco C
Int J Artif Organs; 1999 Mar; 22(3):145-50. PubMed ID: 10357242
[TBL] [Abstract][Full Text] [Related]
7. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
Bellomo R; McGrath B; Boyce N
Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
[TBL] [Abstract][Full Text] [Related]
8. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.
Bouman CS; Oudemans-Van Straaten HM; Tijssen JG; Zandstra DF; Kesecioglu J
Crit Care Med; 2002 Oct; 30(10):2205-11. PubMed ID: 12394945
[TBL] [Abstract][Full Text] [Related]
9. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D
Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
12. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M
Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
[TBL] [Abstract][Full Text] [Related]
13. Clearance of linezolid via continuous venovenous hemodiafiltration.
Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.
Bellomo R; Farmer M; Boyce N
J Intensive Care Med; 1995; 10(4):187-92. PubMed ID: 10155183
[TBL] [Abstract][Full Text] [Related]
15. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.
Swartz RD; Bustami RT; Daley JM; Gillespie BW; Port FK
Clin Nephrol; 2005 May; 63(5):335-45. PubMed ID: 15909592
[TBL] [Abstract][Full Text] [Related]
16. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
17. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.
Atan R; Peck L; Prowle J; Licari E; Eastwood GM; Storr M; Goehl H; Bellomo R
Crit Care Med; 2018 Oct; 46(10):e988-e994. PubMed ID: 30074491
[TBL] [Abstract][Full Text] [Related]
18. A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure.
Fliser D; Kielstein JT
Curr Opin Crit Care; 2004 Dec; 10(6):483-8. PubMed ID: 15616390
[TBL] [Abstract][Full Text] [Related]
19. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
[TBL] [Abstract][Full Text] [Related]
20. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
